| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/04/1998 | EP0825996A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
| 03/04/1998 | EP0825993A1 Xanthines and their therapeutic use |
| 03/04/1998 | EP0825875A1 Therapeutic composition comprising an antigen or an in vivo generator for generating a compound comprising an amino acid sequence |
| 03/04/1998 | EP0825873A2 Anticancer vaccine comprising il6/il6 receptor transfected cells |
| 03/04/1998 | EP0825848A1 Novel collagen formulations |
| 03/04/1998 | EP0644948B1 Anti-receptor antibodies to the vitamin b12/transcobalamin ii receptor |
| 03/04/1998 | EP0617614B1 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor |
| 03/04/1998 | CN1175260A Induction of cytotoxic t -lymphocyte responses |
| 03/04/1998 | CN1175252A Imidazole derivatives as protein kinase inhibitors in particular egf-rthyrosine kinase |
| 03/04/1998 | CN1175210A 4,4-(disubstituted) cyclohexan-1-ols and related compounds |
| 03/04/1998 | CN1174838A Taxusane phosphonic oxygen methyl ether derivant |
| 03/04/1998 | CN1174836A Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 03/04/1998 | CN1174835A Salts of ethyl 3 -(2 -(4 -(4 -(amino-imino-methyl) phenyl) -4 -methyl -2, 5 -dioxo -imidazolidin -1 -yl) acetylamino) -3 -phenylpropionate |
| 03/04/1998 | CN1174717A Traditional Chinese medicine for curing gastric disease |
| 03/04/1998 | CN1174707A Lucid ganoderma oral liquid and preparation process |
| 03/04/1998 | CN1174702A Agent for slow releasing medicine |
| 03/04/1998 | CN1037574C Method for preparation of medicinal composition containing water soluble camptothecin analogs |
| 03/03/1998 | US5723707 Dehydrogenation processes, equipment and catalyst loads therefor |
| 03/03/1998 | US5723635 Centrifugal partition chromatography |
| 03/03/1998 | US5723634 Metal alkoxide compounds |
| 03/03/1998 | US5723632 Multistage chemical condensation with coupling and basification |
| 03/03/1998 | US5723607 Chemical intermediates, enzyme inhibitors, antitumor agents, antigrowth agents |
| 03/03/1998 | US5723589 Nonglycoside linkage |
| 03/03/1998 | US5723485 Analgesic, antiinflammatory agents |
| 03/03/1998 | US5723483 Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensin receptors, their preparation and pharmaceutical compositions containing them |
| 03/03/1998 | US5723480 Adhesion receptor antagonists III |
| 03/03/1998 | US5723315 Secreted proteins and polynucleotides encoding them |
| 03/03/1998 | US5723313 ARF-p19, a novel regulator of the mammalian cell cycle |
| 03/03/1998 | US5723291 Methods for screening compounds for estrogenic activity |
| 03/03/1998 | US5723125 Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide |
| 03/03/1998 | US5723121 Sugar modified interferon |
| 03/03/1998 | US5723120 Method of treating an IL-6 related disease with interleukin-6 receptor antagonists |
| 03/02/1998 | CA2213690A1 Use of retinoid in preparing a medication to treat disorders related to overexpression of vegf |
| 02/28/1998 | CA2213814A1 Naphthalene compounds, intermediates, formulations, and methods |
| 02/26/1998 | WO1998007880A1 Human endokine alpha |
| 02/26/1998 | WO1998007876A2 Self-replicating episomal expression vectors conferring tissue-specific gene expression |
| 02/26/1998 | WO1998007859A2 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | WO1998007855A2 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | WO1998007841A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 02/26/1998 | WO1998007736A1 Don-1 gene and polypeptides and uses therefor |
| 02/26/1998 | WO1998007727A1 Highly lipophilic camptothecin derivatives |
| 02/26/1998 | WO1998007726A1 Substituted pyrrolopyrimidines and processes for their preparation |
| 02/26/1998 | WO1998007719A1 Arylsulfonylimidazolone derivatives as an antitumor agent |
| 02/26/1998 | WO1998007718A1 Non-peptide bombesin receptor antagonists |
| 02/26/1998 | WO1998007697A1 Arylsulfonylamino hydroxamic acid derivatives |
| 02/26/1998 | WO1998007695A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease |
| 02/26/1998 | WO1998007692A1 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors |
| 02/26/1998 | WO1998007441A1 Allogeneic histocompatibility complexes as mediators of cell destruction |
| 02/26/1998 | WO1998007434A1 Improvements in polymer compositions for chemotherapy and methods of treatment using the same |
| 02/26/1998 | WO1998007433A1 Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles |
| 02/26/1998 | WO1998007409A1 Liposomes containing a cisplatin compound |
| 02/26/1998 | WO1998007321A1 Method for inhibiting the expression of fas |
| 02/26/1998 | WO1997049818A3 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 02/26/1998 | WO1997044063A3 Dha-pharmaceutical agent conjugates |
| 02/26/1998 | WO1997039123A3 Secreted proteins |
| 02/26/1998 | WO1997022621A3 Antineoplastic peptides |
| 02/26/1998 | CA2264284A1 Arylsulfonylamino hydroxamic acid derivatives |
| 02/26/1998 | CA2264220A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease |
| 02/26/1998 | CA2264200A1 Human endokine alpha |
| 02/26/1998 | CA2264192A1 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | CA2264178A1 Method for inhibiting the expression of fas |
| 02/26/1998 | CA2264064A1 Imidazole compounds, compositions and use |
| 02/26/1998 | CA2263894A1 Novel human growth factors |
| 02/26/1998 | CA2263871A1 Allogeneic histocompatibility complexes as mediators of cell destruction |
| 02/26/1998 | CA2263854A1 Don-1 gene and polypeptides and uses therefor |
| 02/26/1998 | CA2263796A1 Self-replicating episomal expression vectors conferring tissue-specific gene expression |
| 02/26/1998 | CA2263754A1 Improvements in polymer compositions for chemotherapy and methods of treatment using the same |
| 02/26/1998 | CA2263192A1 Secreted proteins and polynucleotides encoding them |
| 02/26/1998 | CA2262817A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 02/26/1998 | CA2255966A1 Non-peptide bombesin receptor antagonists |
| 02/26/1998 | CA2232239A1 Mammaglobin, antibodies thereto, and their use for detecting diseases of the breast |
| 02/25/1998 | EP0825256A2 Hybrid cell and its use for the preparation of a drug for the induction of tumourimmunity |
| 02/25/1998 | EP0825255A1 Method of producing activated killer monocytes |
| 02/25/1998 | EP0825186A1 2-Aminobenzazepine derivatives and their use for the treatment of immunosuppression |
| 02/25/1998 | EP0824910A2 Use of a Krill Enzyme for the Treatment of Dental Plaque |
| 02/25/1998 | EP0824583A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states |
| 02/25/1998 | EP0824546A2 Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/25/1998 | EP0824544A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use |
| 02/25/1998 | EP0824543A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use |
| 02/25/1998 | EP0824538A1 Saccharopeptides and derivatives thereof |
| 02/25/1998 | EP0824534A1 9,10 disubstituted camptothecin derivatives with antitumor activity |
| 02/25/1998 | EP0824530A1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 02/25/1998 | EP0824529A1 Benzothiazoles and benzoxazoles, as well as drugs containing them, their use and methods of preparing them |
| 02/25/1998 | EP0824527A1 Quinazoline derivatives |
| 02/25/1998 | EP0824526A1 Quinazoline derivative |
| 02/25/1998 | EP0721447B1 Anthracene derivatives for use as anticancer agent or dye |
| 02/25/1998 | CN1174554A Rapamycin 42-oximes and hydroxylamines |
| 02/25/1998 | CN1174512A Use of methioninase in anti-methionine and anti-homocysteine chemotherapy |
| 02/25/1998 | CN1174507A Antitumor agent potentiator comprising IL-6 antagonist |
| 02/25/1998 | CN1174077A Anticancer bolus with peculiar cure effect |
| 02/24/1998 | US5721362 Process for producing ecteinascidin compounds |
| 02/24/1998 | US5721347 Esters and amides of substituted pyrrole acetic acids |
| 02/24/1998 | US5721337 Human thymosin β15 |
| 02/24/1998 | US5721268 Anticarcinogenic agents |
| 02/24/1998 | US5721267 Chemotherapeutic pyrrolocarbazole derivatives |
| 02/24/1998 | US5721259 antitumor agent; leukemia; 3-amino-2-formylpyridine thiosemicarbazone |
| 02/24/1998 | US5721246 Antitumor agents; low toxicity |
| 02/24/1998 | US5721241 Enzyme inhibitors, their synthesis, and methods for use |
| 02/24/1998 | US5721237 Administering for the selective treatment of cell growth and differentiation |
| 02/24/1998 | US5721236 Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |